1.
Braz. j. microbiol
;
45(2): 559-562, Apr.-June 2014.
Artículo
en Inglés
| LILACS
| ID: lil-723110
RESUMEN
Ochrobactrum anthropi infection in newborn patients is rare, and the treatment is challenging because of its widespread and unpredictable resistance to antimicrobial agents and discrepancies between in vitro susceptibility and in vivo efficacy. We report the clinical and microbiological characteristics of Ochrobactrum anthropi bacteremia in a preterm patient.